Synthesis of Methyl 2-cinnamamido-3-hydroxy propanoate having activity against P388 leukemia cells

6Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Cinnamic acid derivative compound was investigated for the anti-cancer inhibitory activity. To be able to obtain compounds that have bioactivity as above, it is needed to study quantitative structure-activity relationship (QSAR) which is the process by which the chemical structure is quantitatively correlated with biological activity/chemical reactivity. Chemical methods used in synthesizing the chemical of methyl trans-cinnamate derivatives are tailored to match their targeted bioactivities. Here, we investigated the anti-cancer inhibitor compound with the method amidation of cinnamic acid derivative compounds. In this reaction we use two steps to get the target product. Firstly, we hydrolize of methyl trans-cinnamate to cinnamic acid. That reaction has a yield 85.5 % and secondly, we amidate of cinnamic acid to metil 2-cinnamamido-3-hydroxy propanoate has a yield of 51.5%. The compound of metil 2-cinnamamido-3-hydroxy propanoate showed against P388 leukemia cells inhibitory activity with IC 50 = 10.78 μg/mL. © 2014 Teni Ernawati et al.

Cite

CITATION STYLE

APA

Ernawati, T., Anita, Y., Lotulung, P. D., & Hanafi, M. (2014). Synthesis of Methyl 2-cinnamamido-3-hydroxy propanoate having activity against P388 leukemia cells. Journal of Applied Pharmaceutical Science, 4(3), 92–95. https://doi.org/10.7324/JAPS.2014.40318

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free